Altria Group, Inc. (MO)
Buenos Aires Exchange · Argentina · prices in ARS · close of 23 Oct 2026
Key indicators
| Last close | ARS 30,680.00 |
|---|---|
| 52-week range | 20,360.00 – 31,320.00 |
| Return, 1 month / 3 months | +11.2% / +9.1% |
| Return, 1 year / 3 years | +30.0% / +322.8% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 28.3% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 310.80M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Altria Group is an American tobacco company based in Richmond, Virginia. It makes and sells cigarettes, including the Marlboro brand, along with smokeless tobacco products such as chewing tobacco and snuff, and it also offers cigars and pipe tobacco. Its customers are adult tobacco consumers, and its products reach them through wholesalers, distributors and retail outlets across the United States. The company also holds investments in beverage businesses.
The shares are listed on the Buenos Aires Exchange in Argentina under the code MO, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Altria Group, Inc. (MO) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 30,680.00 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 15 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.0% and over the last three months it rose 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | -1.1% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.1% | ||
| 6-month return | 27.2% | ||
| 12-month return, skipping the last month | 17.0% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 310.80M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +11.2% |
| 3 months | +9.1% |
| 6 months | +27.2% |
| 1 year | +30.0% |
| 3 years | +322.8% |
| 5 years | +3,210.5% |
Signals
| 50-day / 200-day average | 27,720.47 / 25,663.95 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 684.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | USD 421.1063 |
| 12 Jun 2026 | USD 402.1375 |
| 25 Mar 2026 | USD 402.1375 |
| 26 Dec 2025 | USD 402.1375 |
| 15 Sep 2025 | USD 402.1375 |
| 13 Jun 2025 | USD 386.9625 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.